Related Experiment Video
Updated: Jun 12, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
[(3)H]ouabain binding to ox brain membranes: Characterization of a high-affinity binding site
M R Mazzoni1, C Martini, A Lucacchini
1Istituto Policattedra di Discipline Biologiche, University of Pisa, Via Bonanno 6, 56100 Pisa, Italy.
Abstract:
The characteristics of [(3)H]ouabain binding were studied in frontal cerebral cortex and striatum of ox brain. Specific [(3)H]ouabain binding reached equilibrium in approx. 40 min and was stable for at least 90 min. In frontal cortex membranes, Scatchard analysis revealed a single class of high-affinity binding sites with an apparent dissociation constant (K(d)) of 14 +/- 2.0 nM and a maximal number of binding sites (B(max)) of about 44.7 +/- 3.8 pmol/mg protein. A similar monophasic Scatchard plot was found in striatal membranes. The density of binding sites was of the same magnitude in these two cerebral areas, but striatal sites showed a lower binding affinity. The addition of K(+) or of Ca(2+) to the assay also reduced specific binding and the rank order of inhibitory potencies was similar to that previously reported for inhibition of [(3)H]ouabain binding to rat brain. All cardiac glycosides which were so far tested inhibited specific [(3)H]ouabain binding to frontal cortex membranes. Ouabain was the most potent compound tested (IC(50) 18.3 nM) while digoxigenin was the least potent (IC(50) 112.3 nM). Theophylline was a very weak inhibitor of specific binding. These results suggest the presence of high-affinity [(3)H]ouabain binding sites in ox brain membranes, and are related to previous reports for ouabain binding to human and rat brain.
More Related Videos
10:16Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Quantitative Aspects of Drug-Receptor Interaction
Opioid Receptors: Overview
The Equilibrium Binding Constant and Binding Strength
Ligand Binding and Linkage
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...